Código QR (código de barras bidimensional)

Real‐world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer

Abstract Background The optimal adjuvant endocrine therapy (ET) in hormone receptor positive (HR+) and human epidermal growth factor receptor 2 positive (HER2+) premenopausal breast cancer (BC) remains unclear. Moreover, the benefit and clinical indications of ovarian suppression (OS) is poorly eluc...

תיאור מלא

שמור ב:
Principais autores: Jasmine S. Sukumar, Sagar Sardesai, Andy Ni, Nicole Williams, Kai Johnson, Dionisia Quiroga, Bhuvana Ramaswamy, Robert Wesolowski, Mathew Cherian, Daniel G. Stover, Margaret Gatti‐Mays, Ashley Pariser, Preeti Sudheendra, Mridula A. George, Maryam Lustberg
פורמט: Artigo
שפה:Inglês
יצא לאור: Wiley 2024-06-01
סדרה:Cancer Medicine
נושאים:
adjuvant therapy
breast cancer
endocrine therapy
HER2‐positive
hormone receptor positive
premenopausal
גישה מקוונת:https://doi.org/10.1002/cam4.7317
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים